External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ESMO GI 2026

-
Coming soon
01:30 PM
Duration 60mins Munich, Germany
Safety, Pharmacokinetics, and Clinical Activity of Mosperafenib (RG6344) in Patients with BRAF V600E-mutant Metastatic Colorectal Cancer
E Fontana, C H Han, E Castanon, D J Pinato, O Bechter, R L Eefsen, I Moreno, R Plummer, H Prenen, R Dummer, G Schnetzler, D Dejardin, M About, E Guarin, E Cinato, N Flinn, N A Kratochwil, A Roller, N Keshelava, M Vieito

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Munich, Germany
Impact of liquid biopsy on diagnosis optimisation for advanced cancers: Primary analysis of the L1st gastrointestinal (GI) cohort
C. Benedikt Westphalen, Michele Milella, Vivek Muthu, Fortunato Ciardiello Solange Peters, Luisa Sánchez Lorenzo, Anne-Marie Baird, Allesandro Russo, Maximilian Christopeit, Fethi Touri, Mehlika Hazar Rethinam, Yanling Jin, Andrea D'Ambrogio, Fabrice Barlesi

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Munich, Germany
Phase I/Ib study of divarasib (DIVA) + cetuximab (CETUX) ± FOLFOX for KRAS G12C-mutated (mut) metastatic colorectal cancer (mCRC)
Eric Chen, Marwan Fakih, Sae-Won Han, Hao-Wei Teng, Jeanne Tie, Elisa Fontana, Yu-Min Yeh, Keun-Wook Lee, Katrina Pedersen, Saket Jain, Mariah Clarisse Mayo, Vanessa Breton, Shinsuke Takata, Janet Lau, Edward Cha, Iman Imanirad

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:15 PM
Duration 60mins Munich, Germany
Navigating new evidence in HCC and early CRC: From clinical trial to clincal practice
Arndt Vogel

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
02:50 PM
Duration 10mins Munich, Germany
Does Duration of Adjuvant FOLFOX or Atezolizumab Matter?
Anke Reinacher-Schick, F.-S. Ou, D. Hsu, C. H. Lieu, D. Cohen, K. Matin, W.R. Peters, R.J. Behrens, A. Shergill, P. Mehan, P. J. Gold, M. Khalil, T. Zemla, E. M. O'Reilly, J. Meyerhardt, D. Arnold, F. A. Sinicrope

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar